Main Menu

Publications Highlights View all by category

Types of Publications


Journal Articles

Sud, A. Parry, E.M. Wu, C.J. (2024). The molecular map of CLL and Richter's syndrome. Seminars in hematology, .

Hemminki, K. Hemminki, J. Försti, A. Sud, A. (2023). Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment. , .  show abstract

Huntley, C. Torr, B. Sud, A. Rowlands, C.F. Way, R. Snape, K. Hanson, H. Swanton, C. Broggio, J. Lucassen, A. McCartney, M. Houlston, R.S. Hingorani, A.D. Jones, M.E. Turnbull, C. (2023). Utility of polygenic risk scores in UK cancer screening: a modelling analysis. , .  show abstract

El-Sharkawi, D. Sud, A. Prodger, C. Khwaja, J. Shotton, R. Hanley, B. Peacock, V. Peng, Y.Y. Arasaretnam, A. Sharma, S. Aldridge, F. Sharma, B. Wotherspoon, A. Cheung, B. De Lord, C. Johnston, R. Kassam, S. Pettengel, R. Linton, K. Greaves, P. Cook, L. Naresh, K.N. Cwynarski, K. Eyre, T.A. Chau, I. Cunningham, D. Iyengar, S. (2023). A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications. , .

Sud, A. Horton, R.H. Hingorani, A.D. Tzoulaki, I. Turnbull, C. Houlston, R.S. Lucassen, A. (2023). Realistic expectations are key to realising the benefits of polygenic scores. , .  show abstract

HaemSTAR Collaborators,, (2022). Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019. , Vol.20 (6), pp. 1428-1436.  show abstract

Vickers, A.J. Sud, A. Bernstein, J. Houlston, R. (2022). Polygenic risk scores to stratify cancer screening should predict mortality not incidence. , Vol.6 (1), p. 32.  show abstract

Sud, A. Law, P.J. Houlston, R.S. (2021). The clinical utility of polygenic risk scores for chronic lymphocytic leukemia. Leukemia, .

Hemminki, K. Försti, A. Houlston, R. Sud, A. (2021). Epidemiology, genetics and treatment of multiple myeloma and precursor diseases. International journal of cancer, .  show abstract

Sud, A. Turnbull, C. Houlston, R. (2021). Will polygenic risk scores for cancer ever be clinically useful?. Npj precision oncology, .

Bird, S. Panopoulou, A. Shea, R.L. Tsui, M. Saso, R. Sud, A. West, S. Smith, K. Barwood, J. Kaczmarek, E. Panlaqui, C. Kaiser, M. Stern, S. Pawlyn, C. Boyd, K. (2021). Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. The lancet. haematology, .

Sud, A. Jones, M.E. Broggio, J. Loveday, C. Torr, B. Garrett, A. Nicol, D.L. Jhanji, S. Boyce, S.A. Gronthoud, F. Ward, P. Handy, J.M. Yousaf, N. Larkin, J. Suh, Y.-. Scott, S. Pharoah, P.D. Swanton, C. Abbosh, C. Williams, M. Lyratzopoulos, G. Houlston, R. Turnbull, C. (2020). Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Annals of oncology : official journal of the european society for medical oncology, Vol.31 (8), pp. 1065-1074.  show abstract

Sud, A. Torr, B. Jones, M.E. Broggio, J. Scott, S. Loveday, C. Garrett, A. Gronthoud, F. Nicol, D.L. Jhanji, S. Boyce, S.A. Williams, M. Riboli, E. Muller, D.C. Kipps, E. Larkin, J. Navani, N. Swanton, C. Lyratzopoulos, G. McFerran, E. Lawler, M. Houlston, R. Turnbull, C. (2020). Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. The lancet. oncology, Vol.21 (8), pp. 1035-1044.  show abstract

Chattopadhyay, S. Zheng, G. Sud, A. Sundquist, K. Sundquist, J. Försti, A. Houlston, R. Hemminki, A. Hemminki, K. (2020). Second primary cancers in non-Hodgkin lymphoma: Family history and survival. International journal of cancer, Vol.146 (4), pp. 970-976.  show abstract

Loveday, C. Sud, A. Jones, M.E. Broggio, J. Scott, S. Gronthound, F. Torr, B. Garrett, A. Nicol, D.L. Jhanji, S. Boyce, S.A. Williams, M. Barry, C. Riboli, E. Kipps, E. McFerran, E. Muller, D.C. Lyratzopoulos, G. Lawler, M. Abulafi, M. Houlston, R.S. Turnbull, C. (2020). Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study. Gut, .  show abstract

Zheng, G. Chattopadhyay, S. Sud, A. Sundquist, K. Sundquist, J. Försti, A. Houlston, R. Hemminki, A. Hemminki, K. (2019). Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia. British journal of haematology, Vol.185 (2), pp. 232-239.  show abstract

Went, M. Sud, A. Li, N. Johnson, D.C. Mitchell, J.S. Kaiser, M. Houlston, R.S. (2019). Regions of homozygosity as risk factors for multiple myeloma. Annals of human genetics, Vol.83 (4), pp. 231-238.  show abstract

Loveday, C. Sud, A. Litchfield, K. Levy, M. Holroyd, A. Broderick, P. Kote-Jarai, Z. Dunning, A.M. Muir, K. Peto, J. Eeles, R. Easton, D.F. Dudakia, D. Orr, N. Pashayan, N. UK Testicular Cancer Collaboration,, PRACTICAL Consortium,, Reid, A. Huddart, R.A. Houlston, R.S. Turnbull, C. (2019). Runs of homozygosity and testicular cancer risk. Andrology, Vol.7 (4), pp. 555-564.  show abstract

Sud, A. Chattopadhyay, S. Thomsen, H. Sundquist, K. Sundquist, J. Houlston, R.S. Hemminki, K. (2019). Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk. Blood, Vol.134 (12), pp. 960-969.  show abstract

Law, P.J. Timofeeva, M. Fernandez-Rozadilla, C. Broderick, P. Studd, J. Fernandez-Tajes, J. Farrington, S. Svinti, V. Palles, C. Orlando, G. Sud, A. Holroyd, A. Penegar, S. Theodoratou, E. Vaughan-Shaw, P. Campbell, H. Zgaga, L. Hayward, C. Campbell, A. Harris, S. Deary, I.J. Starr, J. Gatcombe, L. Pinna, M. Briggs, S. Martin, L. Jaeger, E. Sharma-Oates, A. East, J. Leedham, S. Arnold, R. Johnstone, E. Wang, H. Kerr, D. Kerr, R. Maughan, T. Kaplan, R. Al-Tassan, N. Palin, K. Hänninen, U.A. Cajuso, T. Tanskanen, T. Kondelin, J. Kaasinen, E. Sarin, A.-. Eriksson, J.G. Rissanen, H. Knekt, P. Pukkala, E. Jousilahti, P. Salomaa, V. Ripatti, S. Palotie, A. Renkonen-Sinisalo, L. Lepistö, A. Böhm, J. Mecklin, J.-. Buchanan, D.D. Win, A.-. Hopper, J. Jenkins, M.E. Lindor, N.M. Newcomb, P.A. Gallinger, S. Duggan, D. Casey, G. Hoffmann, P. Nöthen, M.M. Jöckel, K.-. Easton, D.F. Pharoah, P.D. Peto, J. Canzian, F. Swerdlow, A. Eeles, R.A. Kote-Jarai, Z. Muir, K. Pashayan, N. PRACTICAL consortium,, Harkin, A. Allan, K. McQueen, J. Paul, J. Iveson, T. Saunders, M. Butterbach, K. Chang-Claude, J. Hoffmeister, M. Brenner, H. Kirac, I. Matošević, P. Hofer, P. Brezina, S. Gsur, A. Cheadle, J.P. Aaltonen, L.A. Tomlinson, I. Houlston, R.S. Dunlop, M.G. (2019). Association analyses identify 31 new risk loci for colorectal cancer susceptibility. Nature communications, Vol.10 (1), pp. 2154-?.  show abstract

Labreche, K. Daniau, M. Sud, A. Law, P.J. Royer-Perron, L. Holroyd, A. Broderick, P. Went, M. Benazra, M. Ahle, G. Soubeyran, P. Taillandier, L. Chinot, O.L. Casasnovas, O. Bay, J.-. Jardin, F. Oberic, L. Fabbro, M. Damaj, G. Brion, A. Mokhtari, K. Philippe, C. Sanson, M. Houillier, C. Soussain, C. Hoang-Xuan, K. Houlston, R.S. Alentorn, A. LOC Network, (2019). A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25 3 and 3p22 1: a LOC network study. Neuro oncol, .  show abstract

Went, M. Kinnersley, B. Sud, A. Johnson, D.C. Weinhold, N. Försti, A. van Duin, M. Orlando, G. Mitchell, J.S. Kuiper, R. Walker, B.A. Gregory, W.M. Hoffmann, P. Jackson, G.H. Nöthen, M.M. da Silva Filho, M.I. Thomsen, H. Broyl, A. Davies, F.E. Thorsteinsdottir, U. Hansson, M. Kaiser, M. Sonneveld, P. Goldschmidt, H. Stefansson, K. Hemminki, K. Nilsson, B. Morgan, G.J. Houlston, R.S. (2019). Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes. Human genomics, Vol.13 (1), pp. 37-?.  show abstract

Takahashi, H. Cornish, A.J. Sud, A. Law, P.J. Disney-Hogg, L. Calvocoressi, L. Lu, L. Hansen, H.M. Smirnov, I. Walsh, K.M. Schramm, J. Hoffmann, P. Nöthen, M.M. Jöckel, K.-. Schildkraut, J.M. Simon, M. Bondy, M. Wrensch, M. Wiemels, J.L. Claus, E.B. Turnbull, C. Houlston, R.S. (2019). Mendelian randomization provides support for obesity as a risk factor for meningioma. Scientific reports, Vol.9 (1), pp. 309-?.  show abstract

Zheng, G. Chattopadhyay, S. Sud, A. Sundquist, K. Sundquist, J. Försti, A. Houlston, R.S. Hemminki, A. Hemminki, K. (2019). Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients. Blood cancer journal, Vol.9 (4), pp. 40-?.

Schmidt, A.F. Holmes, M.V. Preiss, D. Swerdlow, D.I. Denaxas, S. Fatemifar, G. Faraway, R. Finan, C. Valentine, D. Fairhurst-Hunter, Z. Hartwig, F.P. Horta, B.L. Hypponen, E. Power, C. Moldovan, M. van Iperen, E. Hovingh, K. Demuth, I. Norman, K. Steinhagen-Thiessen, E. Demuth, J. Bertram, L. Lill, C.M. Coassin, S. Willeit, J. Kiechl, S. Willeit, K. Mason, D. Wright, J. Morris, R. Wanamethee, G. Whincup, P. Ben-Shlomo, Y. McLachlan, S. Price, J.F. Kivimaki, M. Welch, C. Sanchez-Galvez, A. Marques-Vidal, P. Nicolaides, A. Panayiotou, A.G. Onland-Moret, N.C. van der Schouw, Y.T. Matullo, G. Fiorito, G. Guarrera, S. Sacerdote, C. Wareham, N.J. Langenberg, C. Scott, R.A. Luan, J. Bobak, M. Malyutina, S. Pająk, A. Kubinova, R. Tamosiunas, A. Pikhart, H. Grarup, N. Pedersen, O. Hansen, T. Linneberg, A. Jess, T. Cooper, J. Humphries, S.E. Brilliant, M. Kitchner, T. Hakonarson, H. Carrell, D.S. McCarty, C.A. Lester, K.H. Larson, E.B. Crosslin, D.R. de Andrade, M. Roden, D.M. Denny, J.C. Carty, C. Hancock, S. Attia, J. Holliday, E. Scott, R. Schofield, P. O'Donnell, M. Yusuf, S. Chong, M. Pare, G. van der Harst, P. Said, M.A. Eppinga, R.N. Verweij, N. Snieder, H. Lifelines Cohort authors,, Christen, T. Mook-Kanamori, D.O. ICBP Consortium,, Gustafsson, S. Lind, L. Ingelsson, E. Pazoki, R. Franco, O. Hofman, A. Uitterlinden, A. Dehghan, A. Teumer, A. Baumeister, S. Dörr, M. Lerch, M.M. Völker, U. Völzke, H. Ward, J. Pell, J.P. Meade, T. Christophersen, I.E. Maitland-van der Zee, A.H. Baranova, E.V. Young, R. Ford, I. Campbell, A. Padmanabhan, S. Bots, M.L. Grobbee, D.E. Froguel, P. Thuillier, D. Roussel, R. Bonnefond, A. Cariou, B. Smart, M. Bao, Y. Kumari, M. Mahajan, A. Hopewell, J.C. Seshadri, S. METASTROKE Consortium of the ISGC,, Dale, C. Costa, R.P. Ridker, P.M. Chasman, D.I. Reiner, A.P. Ritchie, M.D. Lange, L.A. Cornish, A.J. Dobbins, S.E. Hemminki, K. Kinnersley, B. Sanson, M. Labreche, K. Simon, M. Bondy, M. Law, P. Speedy, H. Allan, J. Li, N. Went, M. Weinhold, N. Morgan, G. Sonneveld, P. Nilsson, B. Goldschmidt, H. Sud, A. Engert, A. Hansson, M. Hemingway, H. Asselbergs, F.W. Patel, R.S. Keating, B.J. Sattar, N. Houlston, R. Casas, J.P. Hingorani, A.D. (2019). Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. Bmc cardiovascular disorders, Vol.19 (1), pp. 240-?.  show abstract

Disney-Hogg, L. Sud, A. Law, P.J. Cornish, A.J. Kinnersley, B. Ostrom, Q.T. Labreche, K. Eckel-Passow, J.E. Armstrong, G.N. Claus, E.B. Il'yasova, D. Schildkraut, J. Barnholtz-Sloan, J.S. Olson, S.H. Bernstein, J.L. Lai, R.K. Swerdlow, A.J. Simon, M. Hoffmann, P. Nöthen, M.M. Jöckel, K.-. Chanock, S. Rajaraman, P. Johansen, C. Jenkins, R.B. Melin, B.S. Wrensch, M.R. Sanson, M. Bondy, M.L. Houlston, R.S. (2018). Influence of obesity-related risk factors in the aetiology of glioma. British journal of cancer, Vol.118 (7), pp. 1020-1027.  show abstract

Chattopadhyay, S. Zheng, G. Sud, A. Yu, H. Sundquist, K. Sundquist, J. Försti, A. Hemminki, A. Houlston, R. Hemminki, K. (2018). Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden. The lancet. haematology, Vol.5 (8), pp. e368-e377.  show abstract

Turnbull, C. Sud, A. Houlston, R.S. (2018). Cancer genetics, precision prevention and a call to action. Nature genetics, Vol.50 (9), pp. 1212-1218.  show abstract

Takahashi, H. Cornish, A.J. Sud, A. Law, P.J. Kinnersley, B. Ostrom, Q.T. Labreche, K. Eckel-Passow, J.E. Armstrong, G.N. Claus, E.B. Il'yasova, D. Schildkraut, J. Barnholtz-Sloan, J.S. Olson, S.H. Bernstein, J.L. Lai, R.K. Schoemaker, M.J. Simon, M. Hoffmann, P. Nöthen, M.M. Jöckel, K.-. Chanock, S. Rajaraman, P. Johansen, C. Jenkins, R.B. Melin, B.S. Wrensch, M.R. Sanson, M. Bondy, M.L. Turnbull, C. Houlston, R.S. (2018). Mendelian randomisation study of the relationship between vitamin D and risk of glioma. Scientific reports, Vol.8 (1), pp. 2339-?.  show abstract

Chattopadhyay, S. Yu, H. Sud, A. Sundquist, J. Försti, A. Hemminki, A. Hemminki, K. (2018). Multiple myeloma: family history and mortality in second primary cancers. Blood cancer journal, Vol.8 (8), pp. 75-?.

Sud, A. Thomsen, H. Orlando, G. Försti, A. Law, P.J. Broderick, P. Cooke, R. Hariri, F. Pastinen, T. Easton, D.F. Pharoah, P.D. Dunning, A.M. Peto, J. Canzian, F. Eeles, R. Kote-Jarai, Z. Muir, K. Pashayan, N. Campa, D. PRACTICAL Consortium,, Hoffmann, P. Nöthen, M.M. Jöckel, K.-. von Strandmann, E.P. Swerdlow, A.J. Engert, A. Orr, N. Hemminki, K. Houlston, R.S. (2018). Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma. Blood, Vol.132 (19), pp. 2040-2052.  show abstract

Went, M. Sud, A. Försti, A. Halvarsson, B.-. Weinhold, N. Kimber, S. van Duin, M. Thorleifsson, G. Holroyd, A. Johnson, D.C. Li, N. Orlando, G. Law, P.J. Ali, M. Chen, B. Mitchell, J.S. Gudbjartsson, D.F. Kuiper, R. Stephens, O.W. Bertsch, U. Broderick, P. Campo, C. Bandapalli, O.R. Einsele, H. Gregory, W.A. Gullberg, U. Hillengass, J. Hoffmann, P. Jackson, G.H. Jöckel, K.-. Johnsson, E. Kristinsson, S.Y. Mellqvist, U.-. Nahi, H. Easton, D. Pharoah, P. Dunning, A. Peto, J. Canzian, F. Swerdlow, A. Eeles, R.A. Kote-Jarai, Z. Muir, K. Pashayan, N. Nickel, J. Nöthen, M.M. Rafnar, T. Ross, F.M. da Silva Filho, M.I. Thomsen, H. Turesson, I. Vangsted, A. Andersen, N.F. Waage, A. Walker, B.A. Wihlborg, A.-. Broyl, A. Davies, F.E. Thorsteinsdottir, U. Langer, C. Hansson, M. Goldschmidt, H. Kaiser, M. Sonneveld, P. Stefansson, K. Morgan, G.J. Hemminki, K. Nilsson, B. Houlston, R.S. PRACTICAL consortium, (2018). Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma. Nature communications, Vol.9 (1), pp. 3707-?.  show abstract

Disney-Hogg, L. Cornish, A.J. Sud, A. Law, P.J. Kinnersley, B. Jacobs, D.I. Ostrom, Q.T. Labreche, K. Eckel-Passow, J.E. Armstrong, G.N. Claus, E.B. Il'yasova, D. Schildkraut, J. Barnholtz-Sloan, J.S. Olson, S.H. Bernstein, J.L. Lai, R.K. Schoemaker, M.J. Simon, M. Hoffmann, P. Nöthen, M.M. Jöckel, K.-. Chanock, S. Rajaraman, P. Johansen, C. Jenkins, R.B. Melin, B.S. Wrensch, M.R. Sanson, M. Bondy, M.L. Houlston, R.S. (2018). Impact of atopy on risk of glioma: a Mendelian randomisation study. Bmc medicine, Vol.16 (1), pp. 42-?.  show abstract

Chattopadhyay, S. Sud, A. Zheng, G. Yu, H. Sundquist, K. Sundquist, J. Försti, A. Houlston, R. Hemminki, A. Hemminki, K. (2018). Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction. International journal of cancer, Vol.143 (10), pp. 2449-2457.  show abstract

Lawrie, A. Han, S. Sud, A. Hosking, F. Cezard, T. Turner, D. Clark, C. Murray, G.I. Culligan, D.J. Houlston, R.S. Vickers, M.A. (2018). Combined linkage and association analysis of classical Hodgkin lymphoma. Oncotarget, Vol.9 (29), pp. 20377-20385.  show abstract

Kinnersley, B. Sud, A. Coker, E.A. Tym, J.E. Di Micco, P. Al-Lazikani, B. Houlston, R.S. (2018). Leveraging Human Genetics to Guide Cancer Drug Development. Jco clinical cancer informatics, Vol.2, pp. 1-11.  show abstract

Went, M. Sud, A. Speedy, H. Sunter, N.J. Försti, A. Law, P.J. Johnson, D.C. Mirabella, F. Holroyd, A. Li, N. Orlando, G. Weinhold, N. van Duin, M. Chen, B. Mitchell, J.S. Mansouri, L. Juliusson, G. Smedby, K.E. Jayne, S. Majid, A. Dearden, C. Allsup, D.J. Bailey, J.R. Pratt, G. Pepper, C. Fegan, C. Rosenquist, R. Kuiper, R. Stephens, O.W. Bertsch, U. Broderick, P. Einsele, H. Gregory, W.M. Hillengass, J. Hoffmann, P. Jackson, G.H. Jöckel, K.-. Nickel, J. Nöthen, M.M. da Silva Filho, M.I. Thomsen, H. Walker, B.A. Broyl, A. Davies, F.E. Hansson, M. Goldschmidt, H. Dyer, M.J. Kaiser, M. Sonneveld, P. Morgan, G.J. Hemminki, K. Nilsson, B. Catovsky, D. Allan, J.M. Houlston, R.S. (2018). Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology. Blood cancer journal, Vol.9 (1), pp. 1-?.  show abstract

Sud, A. Chattopadhyay, S. Thomsen, H. Sundquist, K. Sundquist, J. Houlston, R.S. Hemminki, K. (2018). Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. Blood, Vol.132 (9), pp. 973-976.

Sud, A. Hemminki, K. Houlston, R.S. (2017). Candidate gene association studies and risk of Hodgkin lymphoma: a systematic review and meta-analysis. Hematological oncology, Vol.35 (1), pp. 34-50.  show abstract

Levy, M. Hall, D. Sud, A. Law, P. Litchfield, K. Dudakia, D. Haugen, T.B. Karlsson, R. Reid, A. Huddart, R.A. Grotmol, T. Wiklund, F. Houlston, R.S. Turnbull, C. (2017). Mendelian randomisation analysis provides no evidence for a relationship between adult height and testicular cancer risk. Andrology, Vol.5 (5), pp. 914-922.  show abstract

May-Wilson, S. Sud, A. Law, P.J. Palin, K. Tuupanen, S. Gylfe, A. Hänninen, U.A. Cajuso, T. Tanskanen, T. Kondelin, J. Kaasinen, E. Sarin, A.-. Eriksson, J.G. Rissanen, H. Knekt, P. Pukkala, E. Jousilahti, P. Salomaa, V. Ripatti, S. Palotie, A. Renkonen-Sinisalo, L. Lepistö, A. Böhm, J. Mecklin, J.-. Al-Tassan, N.A. Palles, C. Farrington, S.M. Timofeeva, M.N. Meyer, B.F. Wakil, S.M. Campbell, H. Smith, C.G. Idziaszczyk, S. Maughan, T.S. Fisher, D. Kerr, R. Kerr, D. Passarelli, M.N. Figueiredo, J.C. Buchanan, D.D. Win, A.K. Hopper, J.L. Jenkins, M.A. Lindor, N.M. Newcomb, P.A. Gallinger, S. Conti, D. Schumacher, F. Casey, G. Aaltonen, L.A. Cheadle, J.P. Tomlinson, I.P. Dunlop, M.G. Houlston, R.S. (2017). Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis. European journal of cancer (oxford, england : 1990), Vol.84, pp. 228-238.  show abstract

Sud, A. Thomsen, H. Law, P.J. Försti, A. Filho, M.I. Holroyd, A. Broderick, P. Orlando, G. Lenive, O. Wright, L. Cooke, R. Easton, D. Pharoah, P. Dunning, A. Peto, J. Canzian, F. Eeles, R. Kote-Jarai, Z. Muir, K. Pashayan, N. PRACTICAL consortium,, Hoffmann, P. Nöthen, M.M. Jöckel, K.-. Strandmann, E.P. Lightfoot, T. Kane, E. Roman, E. Lake, A. Montgomery, D. Jarrett, R.F. Swerdlow, A.J. Engert, A. Orr, N. Hemminki, K. Houlston, R.S. (2017). Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. Nature communications, Vol.8 (1), pp. 1892-?.  show abstract

Sud, A. Hemminki, K. Houlston, R.S. (2017). Second cancer risk following Hodgkin lymphoma. Oncotarget, Vol.8 (45), pp. 78261-78262.

Sud, A. Dearden, C. (2017). T-cell Prolymphocytic Leukemia. Hematol oncol clin north am, Vol.31 (2), pp. 273-283.  show abstract

Sud, A. (2017). Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers. International journal of hematologic oncology, Vol.6 (1), pp. 5-8.

Sud, A. Thomsen, H. Sundquist, K. Houlston, R.S. Hemminki, K. (2017). Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History. J clin oncol, Vol.35 (14), pp. 1584-1590.  show abstract

Sud, A. Kinnersley, B. Houlston, R.S. (2017). Genome-wide association studies of cancer: current insights and future perspectives. Nat rev cancer, Vol.17 (11), pp. 692-704.  show abstract

Li, N. Johnson, D.C. Weinhold, N. Kimber, S. Dobbins, S.E. Mitchell, J.S. Kinnersley, B. Sud, A. Law, P.J. Orlando, G. Scales, M. Wardell, C.P. Försti, A. Hoang, P.H. Went, M. Holroyd, A. Hariri, F. Pastinen, T. Meissner, T. Goldschmidt, H. Hemminki, K. Morgan, G.J. Kaiser, M. Houlston, R.S. (2017). Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism. Cell reports, Vol.20 (11), pp. 2556-2564.  show abstract

Rodriguez-Broadbent, H. Law, P.J. Sud, A. Palin, K. Tuupanen, S. Gylfe, A. Hänninen, U.A. Cajuso, T. Tanskanen, T. Kondelin, J. Kaasinen, E. Sarin, A.-. Ripatti, S. Eriksson, J.G. Rissanen, H. Knekt, P. Pukkala, E. Jousilahti, P. Salomaa, V. Palotie, A. Renkonen-Sinisalo, L. Lepistö, A. Böhm, J. Mecklin, J.-. Al-Tassan, N.A. Palles, C. Martin, L. Barclay, E. Farrington, S.M. Timofeeva, M.N. Meyer, B.F. Wakil, S.M. Campbell, H. Smith, C.G. Idziaszczyk, S. Maughan, T.S. Kaplan, R. Kerr, R. Kerr, D. Passarelli, M.N. Figueiredo, J.C. Buchanan, D.D. Win, A.K. Hopper, J.L. Jenkins, M.A. Lindor, N.M. Newcomb, P.A. Gallinger, S. Conti, D. Schumacher, F. Casey, G. Aaltonen, L.A. Cheadle, J.P. Tomlinson, I.P. Dunlop, M.G. Houlston, R.S. (2017). Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer. International journal of cancer, Vol.140 (12), pp. 2701-2708.  show abstract

Went, M. Sud, A. Law, P.J. Johnson, D.C. Weinhold, N. Försti, A. van Duin, M. Mitchell, J.S. Chen, B. Kuiper, R. Stephens, O.W. Bertsch, U. Campo, C. Einsele, H. Gregory, W.M. Henrion, M. Hillengass, J. Hoffmann, P. Jackson, G.H. Lenive, O. Nickel, J. Nöthen, M.M. da Silva Filho, M.I. Thomsen, H. Walker, B.A. Broyl, A. Davies, F.E. Langer, C. Hansson, M. Kaiser, M. Sonneveld, P. Goldschmidt, H. Hemminki, K. Nilsson, B. Morgan, G.J. Houlston, R.S. (2017). Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach. Blood cancer j, Vol.7 (6), pp. e573-e573.

Law, P.J. Sud, A. Mitchell, J.S. Henrion, M. Orlando, G. Lenive, O. Broderick, P. Speedy, H.E. Johnson, D.C. Kaiser, M. Weinhold, N. Cooke, R. Sunter, N.J. Jackson, G.H. Summerfield, G. Harris, R.J. Pettitt, A.R. Allsup, D.J. Carmichael, J. Bailey, J.R. Pratt, G. Rahman, T. Pepper, C. Fegan, C. von Strandmann, E.P. Engert, A. Försti, A. Chen, B. Filho, M.I. Thomsen, H. Hoffmann, P. Noethen, M.M. Eisele, L. Jöckel, K.-. Allan, J.M. Swerdlow, A.J. Goldschmidt, H. Catovsky, D. Morgan, G.J. Hemminki, K. Houlston, R.S. (2017). Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci. Scientific reports, Vol.7, pp. 41071-?.  show abstract

Sud, A. Morilla, R. Ethell, M. Taussig, D. Liapis, K. (2015). Green‐grey crystals in acute myeloid leukaemia. British journal of haematology, Vol.168 (5), pp. 618-618.

Sud, A. Cooke, R. Swerdlow, A.J. Houlston, R.S. (2015). Genome-wide homozygosity signature and risk of Hodgkin lymphoma. Scientific reports, Vol.5, pp. 14315-?.  show abstract

Hanson, D. Murray, P.G. Coulson, T. Sud, A. Omokanye, A. Stratta, E. Sakhinia, F. Bonshek, C. Wilson, L.C. Wakeling, E. Temtamy, S.A. Aglan, M. Rosser, E.M. Mansour, S. Carcavilla, A. Nampoothiri, S. Khan, W.I. Banerjee, I. Chandler, K.E. Black, G.C. Clayton, P.E. (2012). Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling. Journal of molecular endocrinology, Vol.49 (3), pp. 267-275.  show abstract

Hanson, D. Murray, P.G. Sud, A. Temtamy, S.A. Aglan, M. Superti-Furga, A. Holder, S.E. Urquhart, J. Hilton, E. Manson, F.D. Scambler, P. Black, G.C. Clayton, P.E. (2009). The Primordial Growth Disorder 3-M Syndrome Connects Ubiquitination to the Cytoskeletal Adaptor OBSL1. The american journal of human genetics, Vol.84 (6), pp. 801-806.

Sud, A. Survival trends in hematological malignancies in the nordic countries through 50 years. , .

Went, M. Sud, A. Mills, C. Hyde, A. Culliford, R. Law, P. Vijayakrishnan, J. Kaiser, M. Houlston, R. Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers. , .


Books

(2019). Oxford Handbook for Medical School, Oxford University Press, ISBN: 9780199681907.


Book Chapters

Sud, A. Dearden, C. (2020). Chronic lymphocytic leukaemia. Oxford Desk Reference: Oncology. ISBN: 9780198745440.

In this section

Publications